Description: Taj Pharma, the well-known Lopinavir 100mg and Ritonavir 25mg Tablets manufacturer in India gives the assurance of high-quality and purity. Lopinavir and Ritonavir Tablets (Kyzilitaj) is used to treat human immunodeficiency virus (HIV) infection. Lopinavir and ritonavir are in a class of medications called protease inhibitors. They work by decreasing the amount of HIV in the blood. Lopinavir and Ritonavir Tablets (Kyzilitaj) Suppliers ✓ Finished Lopinavir and Ritonavir Tablets Manufacturers in India – Africa ✓ Middle East ✓ LTAM ✓premium Suppliers & Exporter for Lopinavir 100mg and Ritonavir 25mg Tablets Taj Pharma is a leading manufacturer, supplier, and exporter of Lopinavir 100mg and Ritonavir 25mg Tablets (Kyzilitaj) in India, delivering high-quality antiretroviral medicines to global markets. These tablets are widely used in the management of HIV infection, working by blocking the protease enzyme needed for viral replication, thus lowering the viral load and boosting immune function. Taj Pharma’s WHO-GMP certified manufacturing facilities in Vapi, Gujarat, ensure compliance with stringent international quality standards including USP, BP, and IP. As one of the most trusted Lopinavir and Ritonavir Tablets manufacturers in India, Taj Pharma has an extensive distribution network across PAN India and exports to Africa, Middle East, LATAM, CIS, and Asia. The company is known for its cost-effective pricing, regulatory approvals, and timely global supply. With a focus on patient safety, Taj Pharma ensures rigorous quality checks, reliable packaging, and continuous R&D support. Offering PCD Pharma franchise opportunities, Taj Pharma empowers partners with monopoly rights, marketing support, and profitable margins. Recognized as a top exporter of HIV medicines, Taj Pharma is the preferred partner for NGOs, government procurement, and healthcare providers worldwide. Their commitment to excellence makes them the #1 choice for Lopinavir and Ritonavir Tablets.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 301 KB
